Reframe

Reframe is a cannabis-infused beverage brand producing THC-based spirit alternatives designed to replicate the social and sensory experience of drinking alcohol without its negative effects. The company markets its flagship product as an all-natural, alcohol-free spirit crafted from organic, hemp-derived cannabis. Each 750mL bottle contains 125mg of THC total, delivering approximately 10mg of THC per serving — a dosage calibrated to produce a light, euphoric effect that the brand positions as a functional substitute for traditional alcoholic beverages. Reframe targets health-conscious consumers, sober-curious drinkers, and cannabis enthusiasts seeking a more refined, socially acceptable format for THC consumption beyond edibles or smoking. The product is presented in a traditional spirit bottle format, signaling a deliberate effort to integrate into existing social drinking rituals and occasions. By leveraging the growing hemp-derived cannabinoid market — made broadly accessible following federal hemp legalization — Reframe operates in the rapidly expanding better-for-you beverage and cannabis beverage segment. The use of organic, hemp-derived THC differentiates the product from state-licensed cannabis dispensary products in terms of distribution potential, as hemp-derived THC beverages may be sold through broader retail channels depending on state regulations. The all-natural formulation aligns with clean-label consumer trends prevalent across CPG beverage categories. Reframe competes in the emerging functional and cannabis beverage space alongside other THC-infused drink brands, non-alcoholic spirits, and adaptogen-based beverages. Its positioning — centering on buzz, fun, and ditching alcohol — appeals directly to the millennial and Gen Z demographics driving growth in the no-and-low alcohol movement.

The Nombase Funding database has 4,288 records from over 1,788 companies.

There is 1 funding event for Reframe in the Nombase Funding database.

Unlock exclusive investment and funding data by becoming an Insider and stay ahead with detailed funding rounds, investor info, and more.